Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof

NZ836273APending Publication Date: 2026-08-28GILEAD SCIENCES INC +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: NZ836273
Authority / Receiving Office: NZ · NZ
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2021-08-18
Filing Date: 2022-08-18
Publication Date: 2026-08-28

Application Information

Patent Timeline

18 Aug 2021

Priority

18 Aug 2022

Application

NZ836273

28 Aug 2026

Publication

NZ836273A

IPC: C07D471/04; C07D519/00; A61P3/00; A61P29/02; A61P35/00; A61K31/498

Inventors: KANE, TIM; LEE, JOHN

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure 1_ABST

Patent Text Reader

Abstract

The present disclosure provides bifunctional compounds as IRAK4 degraders via ubiquitin proteasome pathway, and method for treating diseases modulated by IRAK4.

Need to check novelty before this filing date? Find Prior Art